We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Radical Surgery Best for Most Rectal Cancers

By HospiMedica International staff writers
Posted on 16 Jun 2011
A new study recommends that local resection of rectal cancer should be reserved only for superficial tumor stage 1 (T1) disease in patients who will comply with aggressive postoperative surveillance. More...


Researchers at Massachusetts General Hospital (Boston, MA, USA) and the University of Amsterdam (the Netherlands) reviewed the records of 109 consecutive patients with preoperative imaging results suggestive of T1 or T2 disease who underwent total mesorectal excision. All patients underwent preoperative endorectal ultrasonography (US) or magnetic resonance imaging (MRI) and computed tomography (CT), with or without positron emission tomography. Final pathologic investigation identified T3 disease in 27 of the patients. History, physical examination results, and radiologic and pathologic data were evaluated for predictors of positive nodes in the remaining 82 patients.

The results showed that despite indications of negative nodes on radiographic examination, 4 of 35 patients with T1 disease (11%) and 13 of 47 with T2 disease (28%) had positive nodes. The only significant predictor was depth of invasion: 24 of 65 patients with negative nodes (37%) versus 13 of 17 patients with positive nodes (76%) had tumors invading the lower third of the submucosa and beyond. Endorectal US, MRI, and CT (with or without positron emission tomography) used for preoperative staging could not identify these patients reliably. In addition, histologic markers of aggressive disease were not helpful. The study was published in the May 2011 issue of Archives of Surgery.

"Negative results of imaging can be falsely reassuring; because patients with local recurrence have survival rates of 43% to 58% after salvage operations, we believe that local resection should be performed only for superficial T1 tumors, preferably using transanal endoscopic microsurgery, in patients who will adhere to aggressive postoperative surveillance," concluded lead author Harry Salinas, MD, and colleagues of the department of surgery.

Local resection of T1 and T2 rectal cancer results in lower morbidity compared with radical resection. However, recurrence rates after local resection are higher, likely owing to unresected nodal metastasis.

Related Links:
Massachusetts General Hospital
University of Amsterdam



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.